Northern Trust Corp Capricor Therapeutics, Inc. Put Options Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
139Shares Held
12.3MCall Options Held
4.98MPut Options Held
5.48M-
Vanguard Group Inc Valley Forge, PA2.31MShares$18.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$11.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.43 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $196M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...